There are 2934 resources available
5816 - The ImmunoTOX multidisciplinary board, a descriptive study of collaborative management of immune-related adverse events.
Presenter: Jean-Marie Michot
Session: Poster Discussion – Supportive and palliative care
Resources:
Abstract
3064 - Development of GOLD (Geriatric Oncology Liaison Development) service to improve outcomes in older people with cancer
Presenter: Matthaios Kapiris
Session: Poster Discussion – Supportive and palliative care
Resources:
Abstract
6024 - Emergency admissions and bad news disclosure as precipitators of suicide: a territory-wide cohort analysis of 458 oncology patients who completed suicides
Presenter: Tai Chung Lam
Session: Poster Discussion – Supportive and palliative care
Resources:
Abstract
5591 - Worse Patient- Physician Relationship Is Associated With More Fear Of Cancer Recurrence (Deimos Study): A Study Of The Palliative Care Working Committee Of The Turkish Oncology Group (TOG)
Presenter: Ali Alkan
Session: Poster Discussion – Supportive and palliative care
Resources:
Abstract
1090 - Talimogene laherparepvec (T-VEC) in combination (combo) with ipilimumab (ipi) versus ipi alone for advanced melanoma: 3-year landmark analysis of a randomized, open-label, phase 2 trial
Presenter: Jason Chesney
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
1989 - Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study)
Presenter: Henrik Jespersen
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
3622 - Pembrolizumab for Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC): Efficacy and Safety Results From the Phase 2 KEYNOTE-629 Study
Presenter: Jean Jacques Grob
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
3904 - SELPAC - a 3 arm randomised Phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel (PT) in metastatic uveal melanoma (UM)
Presenter: Paul Nathan
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
7194 - Phase II Study of Neoadjuvant Cemiplimab Prior to Surgery in Patients with Stage III/IV (M0) Cutaneous Squamous Cell Carcinoma of the Head and Neck (CSCC-HN)
Presenter: Neil Gross
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
1739 - 18-months relapse-free survival (RFS) and biomarker analyses of OpACIN-neo: a study to identify the optimal dosing schedule of neoadjuvant (neoadj) Ipilimumab (IPI) + Nivolumab (NIVO) in stage III melanoma
Presenter: Elisa Rozeman
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract